| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | - | - | 12.816 | 186.651 |
| Total Income - EUR | - | - | - | - | - | - | - | - | 12.816 | 186.651 |
| Total Expenses - EUR | - | - | - | - | - | - | - | - | 39.697 | 179.855 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | - | - | -26.881 | 6.796 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | - | - | -27.009 | 5.580 |
| Employees | - | - | - | - | - | - | - | - | 2 | 3 |
Check the financial reports for the company - Via Nova Medical S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | - | - | 87.740 | 84.934 |
| Current Assets | - | - | - | - | - | - | - | - | 6.624 | 29.596 |
| Inventories | - | - | - | - | - | - | - | - | 1.145 | 1.426 |
| Receivables | - | - | - | - | - | - | - | - | 3.565 | 18.494 |
| Cash | - | - | - | - | - | - | - | - | 1.914 | 9.676 |
| Shareholders Funds | - | - | - | - | - | - | - | - | -26.807 | -21.077 |
| Social Capital | - | - | - | - | - | - | - | - | 202 | 201 |
| Debts | - | - | - | - | - | - | - | - | 121.170 | 135.606 |
| Income in Advance | - | - | - | - | - | - | - | - | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Via Nova Medical S.r.l.